SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-09-000045
Filing Date
2009-01-30
Accepted
2009-01-30 16:26:22
Documents
1
Group Members
DOMINIQUE SEMONMERLIN BIOMED PRIVATE EQUITY ADVISORS, LLC

Document Format Files

Seq Description Document Type Size
1 ss56389_sc13ga.htm SC 13G/A 107384
  Complete submission text file 0000947871-09-000045.txt   109292
Mailing Address 505 PENOBSCOT DR REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR REDWOOD CITY CA 94063 6503969500
GENELABS TECHNOLOGIES INC /CA (Subject) CIK: 0000874443 (see all company filings)

IRS No.: 943010150 | State of Incorp.: CA | Fiscal Year End: 0131
Type: SC 13G/A | Act: 34 | File No.: 005-42078 | Film No.: 09558622
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169
Business Address 230 PARK AVE, SUITE 928 NEW YORK NY 10169 646-227-5270
Merlin BioMed Private Equity Advisors, L.L.C. (Filed by) CIK: 0001429303 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A